Marshall Wace’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.5K | Sell |
12,800
-307,150
| -96% | -$1.31M | ﹤0.01% | 2445 |
|
|
2025
Q1 | $1.2M | Buy |
319,950
+127,007
| +66% | +$478K | ﹤0.01% | 1603 |
|
|
2024
Q4 | $1.12M | Sell |
192,943
-47,444
| -20% | -$277K | ﹤0.01% | 1559 |
|
|
2024
Q3 | $2.87M | Sell |
240,387
-348,609
| -59% | -$4.16M | ﹤0.01% | 1140 |
|
|
2024
Q2 | $6.37M | Buy |
588,996
+41,193
| +8% | +$446K | 0.01% | 824 |
|
|
2024
Q1 | $6.2M | Buy |
547,803
+257,082
| +88% | +$2.91M | 0.01% | 801 |
|
|
2023
Q4 | $4.08M | Buy |
290,721
+203,987
| +235% | +$2.86M | 0.01% | 811 |
|
|
2023
Q3 | $1.07M | Buy |
+86,734
| New | +$1.07M | ﹤0.01% | 1245 |
|
|
2023
Q2 | – | Sell |
-35,700
| Closed | -$124K | – | 2354 |
|
|
2023
Q1 | $124K | Sell |
35,700
-90,949
| -72% | -$316K | ﹤0.01% | 1982 |
|
|
2022
Q4 | $310K | Sell |
126,649
-20,185
| -14% | -$49.5K | ﹤0.01% | 1972 |
|
|
2022
Q3 | $404K | Buy |
146,834
+9,368
| +7% | +$25.8K | ﹤0.01% | 2116 |
|
|
2022
Q2 | $558K | Buy |
+137,466
| New | +$558K | ﹤0.01% | 2106 |
|
|
2022
Q1 | – | Sell |
-77,092
| Closed | -$721K | – | 3102 |
|
|
2021
Q4 | $721K | Buy |
77,092
+31,514
| +69% | +$295K | ﹤0.01% | 2025 |
|
|
2021
Q3 | $1.26M | Buy |
+45,578
| New | +$1.26M | 0.01% | 1448 |
|